EP-101 STEMVAC

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameEP-101 STEMVAC

Drug Alias NameTh1-selective cancer vaccine (EpiThany)

ClassificationBiologics > Antigen > Tumor antigenVaccines > Application > Therapeutic vaccineVaccines > Development/production technology > Nucleic acid vaccine > DNA vaccine

Mechanisms of ActionImmunomodulators

TargetsNot applicable

Therapy Area/IndicationsSolid tumoursBreast Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaN/A

Originator CompaniesEpithany

China Registration ClassN/A

Develop Information

Active CompaniesEpithany

Inactive CompaniesN/A

Active IndicationsBreast Neoplasms

Inactive IndicationsSolid tumours

Other Information

ATC CodeN/A